# Natalie I. Vokes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/natalie-i-vokes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,379 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 31 |
| i10-index | 61 |
| Last Known Institution | Texas Medical Center |
| OpenAlex ID | https://openalex.org/A5089322688 |
| ORCID iD | 0000-0002-3766-5335 |
| Works | 354 |

## Researcher papers

- [Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis](https://scholariq.org/papers/phosphoglycerate-dehydrogenase-diverts-glycolytic-flux-and-contributes-to/)
- [Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma](https://scholariq.org/papers/integrative-molecular-and-clinical-modeling-of-clinical-outcomes-to-pd1-blockade/)
- [Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities](https://scholariq.org/papers/patterns-of-transcription-factor-programs-and-immune-pathway-activation-define/)
- [Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors](https://scholariq.org/papers/genomic-correlates-of-response-to-immune-checkpoint-blockade-in-microsatellite/)
- [Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma](https://scholariq.org/papers/tumor-and-immune-reprogramming-during-immunotherapy-in-advanced-renal-cell/)
- [Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells](https://scholariq.org/papers/tracing-compartmentalized-nadph-metabolism-in-the-cytosol-and-mitochondria-of/)
- [Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels](https://scholariq.org/papers/association-of-high-tumor-mutation-burden-in-non-small-cell-lung-cancers-with/)
- [Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status](https://scholariq.org/papers/diminished-efficacy-of-programmed-death-ligand-1-inhibition-in-stk11-and-keap1/)
- [Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells](https://scholariq.org/papers/reductive-glutamine-metabolism-is-a-function-of-the-ketoglutarate-to-citrate/)
- [Transcriptional mediators of treatment resistance in lethal prostate cancer](https://scholariq.org/papers/transcriptional-mediators-of-treatment-resistance-in-lethal-prostate-cancer/)
- [Abstract 5882: Genomic correlates of differential response to EGFR-directed tyrosine kinase inhibitors](https://scholariq.org/papers/abstract-5882-genomic-correlates-of-differential-response-to-egfr-directed/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [Texas Medical Center](https://scholariq.org/institutions/texas-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.